Abstract
Neoadjuvant chemotherapy (NACT) is a useful approach in the treatment of many breast cancers. One of the main advantages of NACT is the possibility of breast conservation surgery in patients who would otherwise require a mastectomy. Most literature on NACT focuses on the effectiveness of different chemotherapy regimen and subsequent mastectomy rates. There is little guidance in the literature on aspects of individual patient management and decision making during NACT. This paper considers practical management advice where NACT is considered and adopted.
Original language | English |
---|---|
Pages (from-to) | 65-71 |
Number of pages | 7 |
Journal | European Journal of Surgical Oncology |
Volume | 18 |
Issue number | 1 |
Early online date | 29 Aug 2008 |
DOIs | |
Publication status | Published - Mar 2009 |
Keywords
- Antineoplastic Agents/therapeutic use
- Breast Neoplasms/drug therapy
- Decision Making
- Female
- Humans
- Neoadjuvant Therapy